BioPharma, Pharma NIH Study: Use of Popular Pain Reliever During Pregnancy Not Linked to Neuro Disorders in Kids By Frank Vinluan
BioPharma, Pharma Drug and Digital Technologies Are Part of NIH’s Long Covid Clinical Trial Plans By Frank Vinluan
BioPharma, Pharma NIH Marburg Vaccine Posts Encouraging Results in First-in-Human Study By Frank Vinluan
Daily, Community Collins’ skillfulpiloting helped NIH steer clear of political minefields By Julie Rovner, Kaiser Health News
BioPharma, Pharma AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions By Frank Vinluan
BioPharma NIH panel contradicts FDA on authorization for convalescent plasma in Covid-19 By Alaric DeArment
BioPharma Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds By Alaric DeArment
BioPharma Moderna reports positive – but still early – data from NIH Covid-19 vaccine trial By Alaric DeArment
BioPharma, Policy Trump’s favorite drug for Covid-19 smacked down in VA study, NIH guidance By Alaric DeArment
BioPharma NIH opens Phase II coronavirus trial with Gilead drug at University of Nebraska By Alaric DeArment
BioPharma, Policy, Opinion Trump’s proposed NIH cuts show disregard for importance of basic research By Alaric DeArment
BioPharma NIH, Gates Foundation invest $200M to develop gene therapies for developing countries By Alaric DeArment
Health Services, BioPharma, Diagnostics NIH research initiative All of Us funds Color Genomics as its genetic counseling service By Kevin Truong
Startups, Devices & Diagnostics Stroke recovery startup Flint Rehab nabs another NIH grant By Kevin Truong
Devices & Diagnostics, Diagnostics Fitbit and NIH boost precision medicine research partnership By Kevin Truong
